Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityActive in the last 2 years

Dan‐Ming Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2180-9226; OpenAlex author ID A5108048755. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. SAE1 May Play a Pro-Carcinogenic Role in Pancreatic Adenocarcinoma: A Comprehensive Study Integrating Multiple Pieces of Evidence. Last author DOI 10.1049/syb2.70017↗
  2. Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput se… Last author DOI 10.1080/07853890.2024.2405879↗
  3. Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma. Last author DOI 10.1007/s10620-022-07771-7↗
  4. Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma. Co-author DOI 10.7717/peerj.8380↗
  5. MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. Last author DOI 10.2147/cmar.s199257↗
  6. Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially‑expressed ci… Co-author DOI 10.3892/ijo.2018.4660↗
  7. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000494468↗
  8. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation. First author DOI 10.3892/mmr.2017.7945↗
  9. Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomin… Co-author DOI 10.2147/ott.s136878↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Chen · 6 shared papers, 2018–2025 · strength 0.76
  2. Yi Chen · 2 shared papers, 2024–2025 · strength 0.43
  3. Su‐Ning Huang · 2 shared papers, 2020–2025 · strength 0.32
  4. Dianzhong Luo · 3 shared papers, 2017–2019 · strength 0.26
  5. Xiang-Yu Gan · 1 shared paper, 2023 · strength 0.17
  6. Zhimin Chen · 1 shared paper, 2019 · strength 0.11
  7. Hong Yang · 1 shared paper, 2019 · strength 0.10
  8. Minhua Rong · 1 shared paper, 2020 · strength 0.09
  9. Xiaoyong Cai · 1 shared paper, 2018 · strength 0.09
  10. Liang Liang Ma · 1 shared paper, 2018 · strength 0.09
  11. Jianjun Li · 1 shared paper, 2018 · strength 0.09
  12. Zucheng Xie · 1 shared paper, 2017 · strength 0.07
  13. Jianghua Liu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.